LP
OYST

Lexington Partners’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History

Lexington Partners’s Portfolio OYST Stock Details OYST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-27,408
Closed -$501K – 4
2021
Q1 		$501K Buy
+27,408
New +$575K 0.26% 4

Other funds holding OYST

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
IFA
Invus Financial Advisors New York $89.2M AUM 10.79% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Lexington Partners's OYST Position: Q2 2021 in Review

Lexington Partners sold out of Oyster Point Pharma, Inc. Common Stock (OYST) in Q2 2021, closing a stake of 27,408 shares — an estimated $501K sold.

Lexington Partners first reported a position in OYST in Q1 2021 and held it in 1 quarter. The position peaked at $501K in Q1 2021. 58 funds tracked by Wall St. Rank hold OYST as of Q2 2021.

  • Lexington Partners reported no remaining Oyster Point Pharma, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Lexington Partners sold 27,408 Oyster Point Pharma, Inc. Common Stock shares in Q2 2021, an estimated $501K.
  • Lexington Partners first reported a position in Oyster Point Pharma, Inc. Common Stock in Q1 2021 and held it in 1 quarter.
  • Lexington Partners's Oyster Point Pharma, Inc. Common Stock position peaked at $501K in Q1 2021.
  • 58 funds tracked by Wall St. Rank held Oyster Point Pharma, Inc. Common Stock as of Q2 2021.

Based on Lexington Partners's 13F filing for Q2 2021, filed 12 Aug 2021.